Teleflex Inc (TFX) Quote - XNYS | Morningstar

Skip to Content

Is it the right time to buy or sell?

Find out with Morningstar Premium

Is it the right time to buy or sell?

Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Mid-Cap Med-Tech Is Mega-Valued: Teleflex, Mettler, Zeiss, and Neogen Look Distinctly Overpriced

Equity Analyst Aaron Degagne

Aaron Degagne Equity Analyst

Analyst Note

| Aaron Degagne | Nov 18, 2021

Most medical technology and device companies under our coverage have economic moats, but attractive valuations are hard to find, and the sector trades at an average price/fair value estimate of 1.33.

Read Full Analysis

Company Profile

Business Description

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (26% of 2020 sales), interventional (15%), surgical (13%), anesthesia (12%), interventional urology (13%), original-equipment manufacturing (7%), and all other (14%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Contact

550 East Swedesford Road, Suite 400
Wayne, PA, 19087

T +1 610 225-6800

www.teleflex.com

Sector Healthcare

Industry Medical Instruments & Supplies

Most Recent Earnings Sep 30, 2021

Fiscal Year End Dec 31, 2021

Stock Type Classic Growth

Employees 14,000

Related

10 Scary Stocks: 2021 Edition

These are the most overpriced stocks in our coverage universe today.

Susan Dziubinski

12 Stocks to Avoid

These stocks are all extremely overvalued by our standards--and carry a good deal of uncertainty, too.

Susan Dziubinski

This ETF Targets an Overlooked Segment of the Market

Large- and small-cap companies are only part of the equation.

Venkata Sai Uppaluri

Stock Strategist

Machinery Stocks for Upbeat Factory Orders

A handful of 4- and 5-star machinery stocks poised for a manufacturing recovery.

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.